Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.
Aravind A MenonSandeep SahayLewis E BravermanHarrison W FarberPublished in: Lung (2019)
Therapy with medications targeting the prostacyclin pathway is a potential risk factor for the development of symptomatic thyroid disease.